DOCSLIB.ORG

Multi-Omics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Multi-Omics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis medRxiv preprint doi: https://doi.org/10.1101/2021.05.22.21257482; this version posted May 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . 1 Multi-omics analysis reveals the impact of microbiota on host metabolism in hepatic steatosis Mujdat Zeybel,1,2,3,# Muhammad Arif,4,# Xiangyu Li,4,# Ozlem Altay,4 Mengnan Shi,4 Murat Akyildiz,1 Burcin Saglam,1 Mehmet Gokhan Gonenli,1 Buket Yigit,1 Burge Ulukan,1 Dilek Ural,5 Saeed Shoaie,4,7 Hasan Turkez,8 Jens Nielsen,9 Cheng Zhang,4,6 Mathias Uhlén,4 Jan Borén,10,* Adil Mardinoglu4,7,* 1Department of Gastroenterology and Hepatology, School of Medicine, Koç University, Istanbul, Turkey 2NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust & University of Nottingham, Nottingham, UK 3Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK 4Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden 5School of Medicine, Koç University, Istanbul, Turkey 6 Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan Province, 450001, China 7Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom 8Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey 9Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden 10Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital Gothenburg, Sweden *Correspondence: [email protected]; [email protected] Emails: [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected] NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2021.05.22.21257482; this version posted May 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . 2 Keywords: Non-alcoholic fatty liver disease: Multi-omics analysis; Metabolomics, Proteomics; gut and oral metagenomics; Systems Biology; Systems Medicine Abstract Non-alcoholic fatty liver disease (NAFLD) is a complex disease involving alterations in multiple biological processes regulated by the interactions between obesity, genetic background and environmental factors including the microbiome. To decipher hepatic steatosis (HS) pathogenesis by excluding critical confounding factors including genetic variants, obesity and diabetes, we characterized 56 heterogeneous NAFLD patients by generating multi-omics data including oral and gut metagenomics as well as plasma metabolomics and inflammatory proteomics data. We explored the dysbiosis in the oral and gut microbiome and revealed host-microbiome interactions based on global metabolic and inflammatory processes. We integrated this multi-omics data using the biological network and identified HS's key features using multi-omics data. We finally predicted HS using these key features and validated our findings in a validation dataset, where we characterized 22 subjects with varying degree of HS. Significance statement The oral and gut microbiota alterations have been linked to NAFLD. There is a lack of data on multi-omics characteristics of hepatic steatosis by exclusion of major confounding factors of obesity and metabolic syndrome. We observed that the oral and gut microbiota remodelling starts at early stages of the NAFLD spectrum, independent of obesity and metabolic syndrome. Our analysis suggested that the bacterial diversity is correlated with multi-omics signatures in NAFLD and our predictive model created based on multi-omics variables can successfully predict hepatic steatosis. The components of the multi-omics signatures may serve as biomarkers and can be pharmaceutically targeted. Future clinical trials with microbiota manipulation could consider intervention at early stages of NAFLD. medRxiv preprint doi: https://doi.org/10.1101/2021.05.22.21257482; this version posted May 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . 3 Introduction Non-alcoholic fatty liver disease (NAFLD) is characterized by deposition of lipid droplets in the liver without significant alcohol consumption and secondary causes. NAFLD constitutes a wide range of the clinical spectrum, including hepatic steatosis (HS) and non-alcoholic steatohepatitis (NASH), which may ultimately lead to advanced fibrosis and cirrhosis. In parallel to ongoing epidemics of obesity, NAFLD incidence is increasing globally, affecting almost one-fourth of the population (Abeysekera et al, 2020; Bugianesi, 2020). Even though NAFLD is becoming a leading aetiology of chronic liver disease, therapeutic approaches for NAFLD are currently limited with lifestyle modifications encompassing dietary intervention and physical activity (Alferink et al, 2019; Romero-Gómez et al, 2017; Sanyal, 2019) Given that NAFLD is closely linked to metabolic syndrome, obesity and type 2 diabetes (T2D), its pathogenesis is remarkably complex. Discoveries of PNPLA3 and TM6SF2 variants have highlighted the pathological processes leading to metabolic disturbances in HS. However, only 10- 20% of NAFLD susceptibility could be attributed to known genetic variants (Eslam & George, 2020). Exploring the connections between the hepatic and extra-hepatic metabolic factors through the generation of the multi-omics data may reveal the underlying molecular mechanisms associated with the disease's occurrence, discovering novel biomarkers and drug targets, and eventually provide further insight for the development of efficient treatment strategies. The dysbiosis and diversity in the oral and gut microbiome have been associated with NAFLD (Boursier et al, 2016; Mardinoglu et al, 2018c) as well as metabolic syndrome (Vrieze et al, 2012; Yuan et al, 2019), type 2 diabetes (Mardinoglu et al, 2019) and obesity (Leung et al, 2016). Studies indicated that microbiome composition changes are associated with advanced hepatic fibrosis (Loomba et al, 2017) and cirrhosis (Bajaj et al, 2014; Lelouvier et al, 2016). Moreover, several multi-omics studies integrated complementary –omics data across various environmental states through systems biology. These studies demonstrated that a multi-omics approach is a powerful tool for understanding the dynamics of biological functions in liver diseases and other associated metabolic conditions (Altay et al, 2019; Mardinoglu et al, 2018a). Here, we performed an in-depth characterization of 56 subjects to decipher NAFLD pathogenesis by excluding critical confounding factors including obesity, diabetes and genetic variant- associated HS (Figure 1A). We collected saliva and faeces samples for studying the dysbiosis in the oral and gut microbiome through the generation of shotgun metagenomics data and identified the key species involved in various stages of HS. Moreover, we performed plasma metabolomics and inflammatory proteomics analysis to explore the host-microbiome interactions. We studied the altered global metabolic and inflammatory processes, and its connections with the species' abundances in the oral and gut microbiome. We integrated this multi-omics data using biological networks and identified key features of HS using multi-omics data. We finally predicted HS using these key features and validated our findings in an independent validation dataset, where we characterized 22 subjects with varying HS. medRxiv preprint doi: https://doi.org/10.1101/2021.05.22.21257482; this version posted May 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . 4 Results The associations between HS and clinical and physical variables We generated data for 56 overweight and obese subjects (BMI>28.8) with a varying degree of HS. We excluded patients if they carry PNPLA3 I148M (homozygous for I148M). We determined HS by the proton density fat fraction, measured by magnetic resonance imaging (MRI-PDFF). We classified the subjects into four different groups: i) 10 subjects with no steatosis (HS<5.5%), ii) 14 subjects with mild steatosis (5.5%≤HS<8%), ii) 20 subjects with moderate steatosis (8.0%≤HS<16.5%) and iv) 12 subjects with severe steatosis (HS ≥16.5%) (Figure 1A-B). We carefully phenotyped these subjects by measuring clinical and physical variables (Dataset S1A- C). We also collected saliva and
Load more

Recommended publications
  • Gut Microbiota and Inflammation
    Nutrients 2011, 3, 637-682; doi:10.3390/nu3060637 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Gut Microbiota and Inflammation Asa Hakansson and Goran Molin * Food Hygiene, Division of Applied Nutrition, Department of Food Technology, Engineering and Nutrition, Lund University, PO Box 124, SE-22100 Lund, Sweden; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +46-46-222-8327; Fax: +46-46-222-4532. Received: 15 April 2011; in revised form: 19 May 2011 / Accepted: 24 May 2011 / Published: 3 June 2011 Abstract: Systemic and local inflammation in relation to the resident microbiota of the human gastro-intestinal (GI) tract and administration of probiotics are the main themes of the present review. The dominating taxa of the human GI tract and their potential for aggravating or suppressing inflammation are described. The review focuses on human trials with probiotics and does not include in vitro studies and animal experimental models. The applications of probiotics considered are systemic immune-modulation, the metabolic syndrome, liver injury, inflammatory bowel disease, colorectal cancer and radiation-induced enteritis. When the major genomic differences between different types of probiotics are taken into account, it is to be expected that the human body can respond differently to the different species and strains of probiotics. This fact is often neglected in discussions of the outcome of clinical trials with probiotics. Keywords: probiotics; inflammation; gut microbiota 1. Inflammation Inflammation is a defence reaction of the body against injury. The word inflammation originates from the Latin word ―inflammatio‖ which means fire, and traditionally inflammation is characterised by redness, swelling, pain, heat and impaired body functions.
    [Show full text]
  • Xiexin Tang Improves the Symptom of Type 2 Diabetic Rats by Modulation of the Gut Microbiota
    www.nature.com/scientificreports OPEN Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota Received: 30 August 2017 Xiaoyan Wei, Jinhua Tao , Suwei Xiao, Shu Jiang, Erxin Shang, Zhenhua Zhu, Dawei Qian Accepted: 13 February 2018 & Jinao Duan Published: xx xx xxxx Type 2 diabetes mellitus (T2DM), a chronic metabolic disease which severely impairs peoples’ quality of life, currently attracted worldwide concerns. There are growing evidences that gut microbiota can exert a great impact on the development of T2DM. Xiexin Tang (XXT), a traditional Chinese medicine prescription, has been clinically used to treat diabetes for thousands of years. However, few researches are investigated on the modulation of gut microbiota community by XXT which will be very helpful to unravel how it works. In this study, bacterial communities were analyzed based on high-throughput 16S rRNA gene sequencing. Results indicated that XXT could notably shape the gut microbiota. T2DM rats treated with XXT exhibited obvious changes in the composition of the gut microbiota, especially for some short chain fatty acids producing and anti-infammatory bacteria such as Adlercreutzia, Alloprevotella, Barnesiella, [Eubacterium] Ventriosum group, Blautia, Lachnospiraceae UCG-001, Papillibacter and Prevotellaceae NK3B31 group. Additionally, XXT could also signifcantly ameliorate hyperglycemia, lipid metabolism dysfunction and infammation in T2DM rats. Moreover, the correlation analysis illustrated that the key microbiota had a close relationship with the T2DM related indexes. The results probably provided useful information for further investigation on its active mechanism and clinical application. T2DM, a chronic metabolic disease characterized by hyperglycemia as a result of insufcient insulin secretion, insulin action or both1, is estimated that its numbers in the adults will increase by 55% by 20352.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Longitudinal Characterization of the Gut Bacterial and Fungal Communities in Yaks
    Journal of Fungi Article Longitudinal Characterization of the Gut Bacterial and Fungal Communities in Yaks Yaping Wang 1,2,3, Yuhang Fu 3, Yuanyuan He 3, Muhammad Fakhar-e-Alam Kulyar 3 , Mudassar Iqbal 3,4, Kun Li 1,2,* and Jiaguo Liu 1,2,* 1 Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China; [email protected] 2 MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China 3 College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China; [email protected] (Y.F.); [email protected] (Y.H.); [email protected] (M.F.-e.-A.K.); [email protected] (M.I.) 4 Faculty of Veterinary and Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan * Correspondence: [email protected] (K.L.); [email protected] (J.L.) Abstract: Development phases are important in maturing immune systems, intestinal functions, and metabolism for the construction, structure, and diversity of microbiome in the intestine during the entire life. Characterizing the gut microbiota colonization and succession based on age-dependent effects might be crucial if a microbiota-based therapeutic or disease prevention strategy is adopted. The purpose of this study was to reveal the dynamic distribution of intestinal bacterial and fungal communities across all development stages in yaks. Dynamic changes (a substantial difference) in the structure and composition ratio of the microbial community were observed in yaks that Citation: Wang, Y.; Fu, Y.; He, Y.; matched the natural aging process from juvenile to natural aging.
    [Show full text]
  • Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
    nutrients Review Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms Annamaria Altomare 1,2 , Claudia Di Rosa 2,*, Elena Imperia 2, Sara Emerenziani 1, Michele Cicala 1 and Michele Pier Luca Guarino 1 1 Gastroenterology Unit, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy; [email protected] (A.A.); [email protected] (S.E.); [email protected] (M.C.); [email protected] (M.P.L.G.) 2 Unit of Food Science and Human Nutrition, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy; [email protected] * Correspondence: [email protected] Abstract: Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder charac- terized by abdominal pain associated with defecation or a change in bowel habits. Gut microbiota, which acts as a real organ with well-defined functions, is in a mutualistic relationship with the host, harvesting additional energy and nutrients from the diet and protecting the host from pathogens; specific alterations in its composition seem to play a crucial role in IBS pathophysiology. It is well known that diet can significantly modulate the intestinal microbiota profile but it is less known how different nutritional approach effective in IBS patients, such as the low-FODMAP diet, could be Citation: Altomare, A.; Di Rosa, C.; responsible of intestinal microbiota changes, thus influencing the presence of gastrointestinal (GI) Imperia, E.; Emerenziani, S.; Cicala, symptoms. The aim of this review was to explore the effects of different nutritional protocols (e.g., M.; Guarino, M.P.L.
    [Show full text]
  • Specific Substrate-Driven Changes in Human Faecal Microbiota Composition Contrast with Functional Redundancy in Short-Chain Fatty Acid Production
    The ISME Journal (2018) 12, 610–622 © 2018 International Society for Microbial Ecology All rights reserved 1751-7362/18 www.nature.com/ismej ORIGINAL ARTICLE Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production Nicole Reichardt1,2, Maren Vollmer1, Grietje Holtrop3, Freda M Farquharson1, Daniel Wefers4, Mirko Bunzel4, Sylvia H Duncan1, Janice E Drew1, Lynda M Williams1, Graeme Milligan2, Thomas Preston5, Douglas Morrison5, Harry J Flint1 and Petra Louis1 1The Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, UK; 2Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 3Biomathematics and Statistics Scotland, Foresterhill, Aberdeen, UK; 4Department of Food Chemistry and Phytochemistry, Karlsruhe Institute of Technology (KIT), Adenauerring 20A, Karlsruhe, Germany and 5Scottish Universities Environmental Research Centre, University of Glasgow, Rankine Avenue, East Kilbride, UK The diet provides carbohydrates that are non-digestible in the upper gut and are major carbon and energy sources for the microbial community in the lower intestine, supporting a complex metabolic network. Fermentation produces the short-chain fatty acids (SCFAs) acetate, propionate and butyrate, which have health-promoting effects for the human host. Here we investigated microbial community changes and SCFA production during in vitro batch incubations of 15 different non-digestible carbohydrates, at two initial pH values with faecal microbiota from three different human donors. To investigate temporal stability and reproducibility, a further experiment was performed 1 year later with four of the carbohydrates. The lower pH (5.5) led to higher butyrate and the higher pH (6.5) to more propionate production.
    [Show full text]
  • Rebuilding the Gut Microbiota Ecosystem
    International Journal of Environmental Research and Public Health Review Rebuilding the Gut Microbiota Ecosystem Antonella Gagliardi, Valentina Totino, Fatima Cacciotti, Valerio Iebba, Bruna Neroni, Giulia Bonfiglio, Maria Trancassini, Claudio Passariello ID , Fabrizio Pantanella and Serena Schippa * Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University of Rome, Rome 00185, Italy; [email protected] (A.G.); [email protected] (V.T.); [email protected] (F.C.); [email protected] (V.I.); [email protected] (B.N.); giulia.bonfi[email protected] (G.B.); [email protected] (M.T.); [email protected] (C.P.); [email protected] (F.P.) * Correspondence: [email protected]; Tel.: +39-339-115-2753 Received: 19 June 2018; Accepted: 4 August 2018; Published: 7 August 2018 Abstract: A microbial ecosystem in which bacteria no longer live in a mutualistic association is called dysbiotic. Gut microbiota dysbiosis is a condition related with the pathogenesis of intestinal illnesses (irritable bowel syndrome, celiac disease, and inflammatory bowel disease) and extra-intestinal illnesses (obesity, metabolic disorder, cardiovascular syndrome, allergy, and asthma). Dysbiosis status has been related to various important pathologies, and many therapeutic strategies aimed at restoring the balance of the intestinal ecosystem have been implemented. These strategies include the administration of probiotics, prebiotics, and synbiotics; phage therapy; fecal transplantation; bacterial consortium transplantation; and a still poorly investigated approach based on predatory bacteria. This review discusses the various aspects of these strategies to counteract intestinal dysbiosis. Keywords: gut microbiota; eubiosis; dysbiosis; therapeutic strategy 1. Introduction Bacteria (bacteriome), fungi (mycome) [1], and viruses (virome) [2] live together in a harmonic and dynamic equilibrium in the intestinal tract.
    [Show full text]
  • Functional Comparison of Bacteria from the Human Gut and Closely
    Functional comparison of bacteria from the human gut and closely related non-gut bacteria reveals the importance of conjugation and a paucity of motility and chemotaxis functions in the gut environment Dragana Dobrijevic, Anne-Laure Abraham, Alexandre Jamet, Emmanuelle Maguin, Maarten van de Guchte To cite this version: Dragana Dobrijevic, Anne-Laure Abraham, Alexandre Jamet, Emmanuelle Maguin, Maarten van de Guchte. Functional comparison of bacteria from the human gut and closely related non-gut bacte- ria reveals the importance of conjugation and a paucity of motility and chemotaxis functions in the gut environment. PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0159030. 10.1371/jour- nal.pone.0159030. hal-01353535 HAL Id: hal-01353535 https://hal.archives-ouvertes.fr/hal-01353535 Submitted on 11 Aug 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License RESEARCH ARTICLE Functional Comparison of Bacteria from the Human Gut and Closely Related Non-Gut Bacteria Reveals
    [Show full text]
  • Transcriptional Interactions Suggest Niche Segregation Among
    LETTERS PUBLISHED: 26 AUGUST 2016 | ARTICLE NUMBER: 16152 | DOI: 10.1038/NMICROBIOL.2016.152 Transcriptional interactions suggest niche segregation among microorganisms in the human gut Damian Rafal Plichta1,2, Agnieszka Sierakowska Juncker1, Marcelo Bertalan1, Elizabeth Rettedal3, Laurent Gautier1,4, Encarna Varela5, Chaysavanh Manichanh5, Charlène Fouqueray6, Florence Levenez6,7,TrineNielsen8,JoëlDoré7,9, Ana Manuel Dantas Machado3, Mari Cristina Rodriguez de Evgrafov3, Torben Hansen8,10, Torben Jørgensen11,12,13, Peer Bork14, Francisco Guarner5, Oluf Pedersen8,11, Metagenomics of the Human Intestinal Tract (MetaHIT) Consortium†,MortenO.A.Sommer3,S.DuskoEhrlich7,9,15, Thomas Sicheritz-Pontén1, Søren Brunak1,16* and H. Bjørn Nielsen1,2* The human gastrointestinal (GI) tract is the habitat for fermentation of complex substrates11 and exchange of metabolites12, hundreds of microbial species, of which many cannot be culti- and antagonistic interactions that include competition for resources13 vated readily, presumably because of the dependencies or adhesion sites14 and the production of antimicrobial compounds15. between species1. Studies of microbial co-occurrence in the At the community level, microbes with shared genetic potential tend gut have indicated community substructures that may reflect to coexist in the human GI tract, which suggests that the microbiome functional and metabolic interactions between cohabiting ensemble is driven by habitat filtering4. Classic population ecology species2,3. To move beyond species co-occurrence networks, theory, however, predicts that competition between two undifferen- we systematically identified transcriptional interactions tiated species eventually will lead to the extinction of one of them16, between pairs of coexisting gut microbes using metagenomics which raises the question of how microbes with overlapping and microarray-based metatranscriptomics data from 233 stool functional potential differentiate in the human GI tract.
    [Show full text]
  • Genome-Based Taxonomic Classification Of
    ORIGINAL RESEARCH published: 20 December 2016 doi: 10.3389/fmicb.2016.02003 Genome-Based Taxonomic Classification of Bacteroidetes Richard L. Hahnke 1 †, Jan P. Meier-Kolthoff 1 †, Marina García-López 1, Supratim Mukherjee 2, Marcel Huntemann 2, Natalia N. Ivanova 2, Tanja Woyke 2, Nikos C. Kyrpides 2, 3, Hans-Peter Klenk 4 and Markus Göker 1* 1 Department of Microorganisms, Leibniz Institute DSMZ–German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany, 2 Department of Energy Joint Genome Institute (DOE JGI), Walnut Creek, CA, USA, 3 Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia, 4 School of Biology, Newcastle University, Newcastle upon Tyne, UK The bacterial phylum Bacteroidetes, characterized by a distinct gliding motility, occurs in a broad variety of ecosystems, habitats, life styles, and physiologies. Accordingly, taxonomic classification of the phylum, based on a limited number of features, proved difficult and controversial in the past, for example, when decisions were based on unresolved phylogenetic trees of the 16S rRNA gene sequence. Here we use a large collection of type-strain genomes from Bacteroidetes and closely related phyla for Edited by: assessing their taxonomy based on the principles of phylogenetic classification and Martin G. Klotz, Queens College, City University of trees inferred from genome-scale data. No significant conflict between 16S rRNA gene New York, USA and whole-genome phylogenetic analysis is found, whereas many but not all of the Reviewed by: involved taxa are supported as monophyletic groups, particularly in the genome-scale Eddie Cytryn, trees. Phenotypic and phylogenomic features support the separation of Balneolaceae Agricultural Research Organization, Israel as new phylum Balneolaeota from Rhodothermaeota and of Saprospiraceae as new John Phillip Bowman, class Saprospiria from Chitinophagia.
    [Show full text]
  • Automated Analysis of Genomic Sequences Facilitates High- Throughput and Comprehensive Description of Bacteria ✉ ✉ Thomas C
    www.nature.com/ismecomms ARTICLE OPEN Automated analysis of genomic sequences facilitates high- throughput and comprehensive description of bacteria ✉ ✉ Thomas C. A. Hitch 1 , Thomas Riedel2,3, Aharon Oren4, Jörg Overmann2,3,5, Trevor D. Lawley6 and Thomas Clavel 1 © The Author(s) 2021 The study of microbial communities is hampered by the large fraction of still unknown bacteria. However, many of these species have been isolated, yet lack a validly published name or description. The validation of names for novel bacteria requires that the uniqueness of those taxa is demonstrated and their properties are described. The accepted format for this is the protologue, which can be time-consuming to create. Hence, many research fields in microbiology and biotechnology will greatly benefit from new approaches that reduce the workload and harmonise the generation of protologues. We have developed Protologger, a bioinformatic tool that automatically generates all the necessary readouts for writing a detailed protologue. By producing multiple taxonomic outputs, functional features and ecological analysis using the 16S rRNA gene and genome sequences from a single species, the time needed to gather the information for describing novel taxa is substantially reduced. The usefulness of Protologger was demonstrated by using three published isolate collections to describe 34 novel taxa, encompassing 17 novel species and 17 novel genera, including the automatic generation of ecologically and functionally relevant names. We also highlight the need to utilise
    [Show full text]
  • Gut Microbiome-Related Effects of Berberine and Probiotics on Type 2 Diabetes (The PREMOTE Study)
    ARTICLE https://doi.org/10.1038/s41467-020-18414-8 OPEN Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) Yifei Zhang 1,19, Yanyun Gu1,19, Huahui Ren2,19, Shujie Wang 1,19, Huanzi Zhong 2,19, Xinjie Zhao3, Jing Ma4, Xuejiang Gu5, Yaoming Xue6, Shan Huang7, Jialin Yang8, Li Chen9, Gang Chen10, Shen Qu11, Jun Liang12, Li Qin13, Qin Huang14, Yongde Peng15,QiLi3, Xiaolin Wang3, Ping Kong2, Guixue Hou 2, Mengyu Gao2, Zhun Shi2, Xuelin Li1, Yixuan Qiu1, Yuanqiang Zou2, Huanming Yang2,16, Jian Wang2,16, ✉ ✉ Guowang Xu3, Shenghan Lai17, Junhua Li 2,18 , Guang Ning1 & Weiqing Wang1 1234567890():,; Human gut microbiome is a promising target for managing type 2 diabetes (T2D). Measures altering gut microbiota like oral intake of probiotics or berberine (BBR), a bacteriostatic agent, merit metabolic homoeostasis. We hence conducted a randomized, double-blind, placebo- controlled trial with newly diagnosed T2D patients from 20 centres in China. Four-hundred- nine eligible participants were enroled, randomly assigned (1:1:1:1) and completed a 12-week treatment of either BBR-alone, probiotics+BBR, probiotics-alone, or placebo, after a one-week run-in of gentamycin pretreatment. The changes in glycated haemoglobin, as the primary outcome, in the probiotics+BBR (least-squares mean [95% CI], −1.04[−1.19, −0.89]%) and BBR-alone group (−0.99[−1.16, −0.83]%) were significantly greater than that in the placebo and probiotics-alone groups (−0.59[−0.75, −0.44]%, −0.53[−0.68, −0.37]%, P < 0.001). BBR treatment induced more gastrointestinal side effects.
    [Show full text]